| Objective:Atherosclerosis(AS)is the main pathological basis for cardiovascular and cerebrovascular diseases and the mechanism is very complex.The deposition and retention of low-density lipoprotein(LDL),especially oxidized low-density lipoprotein(oxLDL)under the vascular endothelium,is considered to be a key factor in the development of AS.We first discovered sialic acid binding immunoglobulin-like lectin-5(siglec-5)was significantly increased in type 2 diabetes mellitus(T2DM)patients with critical limb ischemia(CLI).More interestingly,we confirmed siglec-5 could be observed in atherosclerotic plaques.More and more studies have reported that the Sialic acid binding immunoglobulin-like lectins(siglecs)family is closely related to AS,which is a chronic non-controllable inflammatory disease of the vascular wall.However,the specific role and molecular mechanism of siglec-5 in the formation of atherosclerosis has not been illustrated.This section aims to study the role of siglec-5in the occurrence and development of AS from the perspective of oxLDL transcytosis to provide new targets and treatments for the prevention and treatment of atherosclerosis.Methods:(1)The transcytosis characteristics of oxLDL were detected by an in-vitro transcytosis model,and the transcytosis of LDL and oxLDL was compared.(2)The expression of siglec-5 in HUVECs was observed by semi-quantitative reverse transcription-polymerase chain reaction(RT-PCR)and Western blot.(3)Quantitative RT-PCR and Western blot were used to detect the effects of oxLDL on the expression of siglec-5 mRNA and siglec-5 protein in endothelial cells and macrophages.(4)The effects of siglec-5 on the transcytosis and uptake of oxLDL were detected in endothelial cells by an in-vitro transcytosis model and laser confocal microscopy.(5)The effect of siglec-5 on oxLDL endocytosis was detected in macrophages by cell flow cytometry and laser confocal microscopy.(6)Binding of oxLDL to siglec-5 was detected in endothelial cells by laser confocal microscopy and co-immunoprecipitation.(7)After administration of anti-siglec-5 antibody and soluble siglec-5 protein,the transcytosis of oxLDL in endothelial cells and the endocytosis of oxLDL in macrophages were detected.(8)ApoE-/-mice were overexpressed with exogenous siglec-5 by the adeno-associated virus vector system,and the Oil RedO staining was used to observe lipid deposition in the whole aorta and aortic roots.Results:(1)The in-vitro transcytosis of oxLDL showed that the transcytosis of oxLDL increased with the elevation of oxLDL concentration,indicating that the transcytosis of oxLDL had certain concentration dependence,and oxLDL had a stronger transcytosis effect than LDL.(2)Western blot and laser confocal microscopy showed that siglec-5was expressed on the membrane of endothelial cells.(3)OxLDL could promote the expression of siglec-5 mRNA and siglec-5 protein in endothelial cells and macrophages in a concentration-dependent manner.(4)The knockdown of siglec-5 inhibited the transcytosis of oxLDL,while the overexpression of siglec-5 promoted the transcytosis of oxLDL in endothelial cells.(5)The knockdown of siglec-5 suppressed the endocytosis of oxLDL and the overexpression of siglec-5 promoted the endocytosis of oxLDL in macrophages.(6)Siglec-5 could directly bind to oxLDL and mediate the transcytosis of oxLDL.(7)Anti-siglec-5 antibody and soluble siglec-5 protein not only inhibited the transcytosis of oxLDL in endothelial cells but also attenuated the endocytosis of oxLDL in macrophages.(8)In the ApoE-/-mouse of atherosclerosis model,overexpression of the siglec-5 gene promoted lipid deposition in the whole aorta and aortic roots,while anti-siglec-5 antibody and soluble siglec-5 protein intervention slowed lipid deposition.Conclusions:The transcytosis of oxLDL has a concentration-dependent characteristic,and oxLDL has a stronger transcytosis effect than LDL,which indicates that oxLDL has a more atherogenic effect from the perspective of transcytosis.Siglec-5 was expressed on the membrane of endothelial cells and found that siglec-5 was a novel oxLDL receptor.Through direct binding to oxLDL,siglec-5 not only mediated oxLDL transcytosis in endothelial cells but also mediated oxLDL endocytosis in macrophages,which promoted the formation of macrophage foam cells,thereby accelerating the occurrence and development of atherosclerosis. |